In the cutaneous melanoma cell lines, MEL 04.01 and MEL 06.24, Nutlin-3 treatment increased significantly CDKN1A, CYFIP2 and PTCHD4 expression, whereas PIK3IP1 and MXD4 levels do not or hardly change (Supplementary Figure S3A). This evidence concerns the gene MXD4 and cutaneous melanoma.